Forum Diabetologicum - Issue 3/2022
Editorial
Review Article
129
135
143
New trends in current bariatric-metabolic surgery and their contribution to the treatment of (pre)diabetes
Pavol Holéczy, Matej Pekař, Marek Bužga, Eva Evinová
151
Risk of cancers in the treatment of diabetes mellitus by insulin and sulphonylurea drugs
Marián Mokáň, Peter Galajda
Original Article
157
New criteria for the diagnosis of gestational diabetes mellitus and their consequences
Richard Školka, Karol Dókuš, Silvia Dókušová
Case Reports
165
The status of SGLT2 inhibitors in the current EASD/ADA 2022 therapeutic recommendations for the treatment of type 2 diabetes mellitus and their use in practice: case reports and commentary
Emil Martinka, Viera Šuličová, Gabriela Švrčková, Martina Barátová
Forum Diabetologicum
2022 Issue 3
Most read in this issue
- New criteria for the diagnosis of gestational diabetes mellitus and their consequences
- The status of SGLT2 inhibitors in the current EASD/ADA 2022 therapeutic recommendations for the treatment of type 2 diabetes mellitus and their use in practice: case reports and commentary
- New trends in current bariatric-metabolic surgery and their contribution to the treatment of (pre)diabetes
- Presence and near future of pharmacological treatment of obesity/diabesity